🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a drug-drug interaction (DDI), pharmacokinetics (PK), safety ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-08-14
Trial ID
NCT04493931
Treatments Being Tested
Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II ...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-07-23
Trial ID
NCT03568942
Treatments Being Tested
This is a two-part study which will evaluate the PK, safety, and tolerabili...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-06-14
Trial ID
NCT03562117
Treatments Being Tested
This study is divided in 2 parts. Part 1a is being conducted to evaluate th...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-08-04
Trial ID
NCT02853435
Treatments Being Tested
This is a phase III, randomized, multicenter, open-label study which will b...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-21
Trial ID
NCT04010539
Treatments Being Tested
The study will be conducted to evaluate the therapeutic response (combined ...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-04-23
Trial ID
NCT04187144
Treatments Being Tested
This study is a randomized, open-label, two periods, cross-over pharmacokin...
Status
Completed
Location
GSK Investigational Site
Start Date
2022-03-01
Trial ID
NCT05271799
Treatments Being Tested
The study will be conducted to evaluate the therapeutic response (combined ...
Status
Completed
Location
GSK Investigational Site
Start Date
2019-10-17
Trial ID
NCT04020341
Treatments Being Tested
This is Phase I, 4-period, randomized, active-and placebo-controlled, doubl...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-10-06
Trial ID
NCT02257398
Treatments Being Tested
This study will be conducted in three parts (Part 1, Part 2 and Part 3). Pa...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-01-28
Trial ID
NCT02045849
Treatments Being Tested